A Blog About Intellectual Property Litigation and the District of Delaware


Entries for date: April 2025

You are all of course familiar with the classic tale of chicken little. You may be less familiar with the plot of if the ill-fated Disney move of the same name. They both start the same, chicken sleeping under a tree has something fall on him, tells everyone the sky is falling and starts a panic.

Sahad Babali, Unsplash

Here the stories diverge. In the folktale, chicken little and his panicked friends meet a while fox, who tricks them into taking shelter in his cave, and then eats them. You can see the lesson.

In the film, chicken little is scorned, but later redeems himself by helping the local baseball team win the pennant (?). Afterwards, he is again hit by a piece of the sky, which turns out to be high tech camouflage used to hide alien spaceships in low orbit. The ships descend upon the hapless town, and the whole thing turns out to be a big misunderstanding. The lesson is somewhat less clear. This film made 300 million dollars.

Those of you who read Law360 (who somehow scooped me on this, but whose article does not recount the plot of a 20-year-old children's movie in unnecessary detail) will have guessed that this is all leading up to Judge Andrews' Oral Order yesterday in Novartis Pharmaceuticals Corporation v. Dr. Reddy's Laboratories, Inc., C.A. No. 19-2053-RGA. D.I. 512 (D. Del. Apr. 2, 2025):

Yesterday, MSN said the sky was falling and it needed emergency relief. I granted it. Today, MSN has filed an emergency motion requesting additional relief for essentially the same falling sky. I decline to enter any additional relief at this time or to consider the motion on an emergency basis.

For those wondering about the context here, the Federal Circuit just recently issued its mandate in the case ruling that the asserted patent was valid and infringed. Judge Andrews then promptly entered a final judgment, which included an order setting the effective date for approval of MSN's ANDA until after the end of Novartis' pediatric exclusivity period.

It's unclear from the docket exactly what happened next, but it appears that MSN emailed chambers ...

Courthouse Clock
AI-Generated, displayed with permission

We've written before about how delay can kill your discovery motions. We got another straightforward example on Monday in Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd., C.A. No. 20-133, D.I. 340 (D. Del. Mar 31, 2025).

There, the defendants sought depositions of two foreign inventors through the Hague convention. The defendants have known the relevance of the inventors' knowledge since at least July, 2022, but only moved for issuance of letters rogatory in December 2024.

The case was stayed for a portion of that time, but in total, the Court found that there was no good reason that it should have taken so long to seek this discovery:

During the teleconference, Defendants' …

I will speak a truth that many of you have suspected. Sometimes we (well, I) pick a case just because it has a fun name. My original post today was about HQ Specialty Pharma Corp. v. Fresenius Kabi USA, LLC, C.A. No. 21-1714-MN. Honestly the case was too fact intensive to easily convert to a general interest blog post. On the other hand, it contained a great deal of discussion of the testimony of a New Jersey Pharmaceutical executive named Mr. Pizza.

"I'm cooked!" AI-Generated, displayed with permission

The whole thing ended up being just jokes and out of context slices ("Mr. Kelly . . . doubted whether Mr. Pizza 'had any knowledge of the [prior art] references'") …